Study identifies a promising target for polycystic kidney disease treatment

Blocking the inhibition of PKD1 and PKD2 gene expression by deleting a binding site for microRNAs hindered the formation and growth of kidney cysts in autosomal dominant polycystic kidney disease (ADPKD) models, UT Southwestern researchers reported.

Related Keywords

Texas ,United States ,Patricia Cobo ,Andrea Flaten ,Jesus Alvarez ,Darrenp Wallace ,Vishal Patel ,Edmundc Lee ,Emily Henderson ,Ronak Lakhia ,Harini Ramalingam ,Laurence Biggers ,Nature Communications ,National Institutes Of Health ,Department Of Defense ,Division Of Nephrology ,Associate Professor ,Internal Medicine ,Assistant Professor ,Patricia Cobo Stark ,Chun Mien Chang ,Tania Valencia ,National Institutes ,Regulus Therapeutics ,Gene ,Gene Therapy ,Kidney ,Kidney Disease ,Polycystic Kidney Disease ,Autosomal ,Autosomal Dominant Polycystic Kidney Disease ,Cyst ,Ene Expression ,Genes ,Enetic ,Kidney Cyst ,Kidney Failure ,Medicine ,Nephrology ,Protein ,Research ,